|   |
KEYNOTE SPEAKERS:  
 |
Robert A. Kramer Vice President for Oncology Drug Discovery Bristol-Myers Squibb   |
 |
Glenn Begley Vice President & Global Head of Hematology & Oncology Research Amgen |
DISTINGUISHED SPEAKERS:
Rula Abbud-Antaki President and CSO Falcon Genomics
Timothy M. Block President, Hepatitis B Foundation and Professor Drexel University
Darren D. Browning Associate Professor and Graduate Program Director Medical College of Georgia
Isabelle Dussault Director of Research Amgen
Edward Esposito Chief Scientist P.A. Technologies
Christian Fritz Senior Director, Cancer Biology Infinity Pharmaceuticals
Peixuan Guo Professor  and Director of NIH Nanomedicine Development Center Purdue University
Jutta Heim Chief Scientific Officer Basilea Pharmaceutica AG
Douglas Laird Senior Scientist, Pharmacology Exelixis
Xuesong Liu Principle Investigator Abbott Laboratories
Liqin Liu Research Scientist Amgen
John Martens Senior Scientist, Department of Medical Oncology Erasmus Medical Center
Marcia Moss BioZyme Inc.
Beverly Packard President OncoImmunin, Inc.   Daniel Powell Jr. Deputy Director Cell & Vaccine Production Facility University of Pennsylvania
Vanitha Ramakrishnan Associate Director Genentech
Richard Rickles Director, Oncology CombinatoRx
Dinah Sah Senior Director, Research Alnylam Pharmaceuticals
Nathalie Scholler Assistant Professor University of Pennsylvania   Jeffery Schlom Chief, Laboratory of Tumor Immunology and Biology NIH/NCI   Liang Schweizer Oncology Drug Discovery Bristol-Myers Squibb
Kunwar Shailubhai CSO Synergy Pharmaceuticals, Inc
Domagoj Vucic Scientist, Protein Engineering Genentech
Yumiko Wada Senior Director Synta Pharmaceuticals
 
|
|